[1]王 珏,施万印.抗凝、抗血小板及溶栓药物的合理应用[J].介入放射学杂志,2011,(01):76-81.
 WANG Jue,SHI Wan-yin..The rational application of the anticoagulative, antiplatelet and thrombolytic drugs[J].journal interventional radiology,2011,(01):76-81.
点击复制

抗凝、抗血小板及溶栓药物的合理应用()

PDF下载中关闭

分享到:

《介入放射学杂志》[ISSN:1008-794X/CN:31-1796/R]

卷:
期数:
2011年01期
页码:
76-81
栏目:
讲 座
出版日期:
2011-01-15

文章信息/Info

Title:
The rational application of the anticoagulative, antiplatelet and thrombolytic drugs
作者:
王 珏 施万印
200233 上海交通大学附属第六人民医院介入影像科
Author(s):
WANG Jue SHI Wan-yin.
Department of Diagnostic and Interventional Radiology, the Affiliated Sixth People’s Hospital, School of Medicine, Shanghai Jiaotong University, Shanghai 200233, China
关键词:
抗凝药物 抗血小板药物 溶栓药物 临床应用
分类号:
文献标志码:
摘要:
抗凝、抗血小板及溶栓药物是主要针对高危患者预防和治疗血栓形成、栓塞的一类药物,已广泛应用于血管成形和支架植入术。但抗凝、溶栓及抗血小板药物伴随一些不良反应,如出血、血小板减少症等。认识抗凝、溶栓及抗血小板药物的作用机制、适应证并加强监测,有助于我们合理、有效的选用药物,预防和减少不良反应和严重并发症的发生。

参考文献/References:

[1] de Bruijn SF, Stam J. Randomizsed, placebo-controlled trial of anticoagulant treatment with low-molecular-weight heparin for cerebral sinus thrombosis[J]. Stroke, 1999, 30: 484 - 488.
[2] 梁 瑛. 常用溶栓?抗凝药物[J]. 中国全科医学, 2003, 6: 857 - 858.
[3] Einhaupl KM, Villringer A, Meister W, et al. Heparin treatment in sinus venous thrombosis [J]. Lancet, 1991, 338: 597 - 600.
[4] Stam J, de Bruijn S, deVeber G. Anticoagulation for cerebral sinus thrombosis[J]. Stroke, 2003, 34: 1054 - 1055.
[5] 周 平, 李法琦. 常用抗血小板和抗凝药物在心脑血管疾病中的应用[J]. 心血管病学进展, 2004, 25: 338 - 341.
[6] 潘春梅, 向定成. 抗凝药比伐卢定国外临床应用进展[J]. 中国新药杂志, 2008, 17: 725 - 727.
[7] 王 珏, 程永德. 介入放射药物治疗学[M]. 北京: 科学出版社, 2009: 62.
[8] Weitz JI, Hirsh J, Samama MM, et al. New antithrombotic drugs: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition)[J]. Chest(6 supp 1), 2008, 133: 234S - 256S.
[9] 王拥军. 分层理念贯穿卒中防治始终[J]. 中国卒中杂志, 2009, 4: 10 - 12.
[10] 王鸿利. 抗凝药物和溶栓药物的临床应用和实验监测[J]. 内科急危重症杂志, 2001, 7: 184 - 189.
[11] Weimar C, Kraywinkel K, Maschke M, et al. Intravenous thrombolysis in geman stroke units before and after regulatory approval of recombinant tissue plasminogen activator[J]. Cerebrovasc Dis, 2006, 22: 429 - 431.
[12] Caplan LR. Thrombolysis 2004: the good, the bad, and the ugly[J]. Rev Neurol Dis, 2004, 1: 16 - 26.



 

相似文献/References:

[1]潘 曼,李海燕,齐戈尧.动脉粥样硬化患者介入术后服用抗血小板药物的依从性及其影响因素[J].介入放射学杂志,2022,31(09):917.
 PAN Man,LI Haiyan,QI Geyao..The adherence of taking antiplatelet drugs in patients with atherosclerosis after receiving interventional therapy and analysis of its influencing factors[J].journal interventional radiology,2022,31(01):917.

备注/Memo

备注/Memo:
收稿日期:20100210
更新日期/Last Update: 2011-01-15